Gerber Kawasaki Wealth & Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $471K | Sell |
19,574
-1,868
| -9% | -$48.9K | 0.01% | 239 |
|
|
2026
Q1 | $602K | Buy |
21,442
+1,627
| +8% | +$43.3K | 0.02% | 204 |
|
|
2025
Q4 | $493K | Buy |
19,815
+313
| +2% | +$7.89K | 0.02% | 223 |
|
|
2025
Q3 | $497K | Sell |
19,502
-585
| -3% | -$14.4K | 0.02% | 212 |
|
|
2025
Q2 | $487K | Sell |
20,087
-1,536
| -7% | -$35.8K | 0.02% | 206 |
|
|
2025
Q1 | $548K | Buy |
21,623
+987
| +5% | +$25.8K | 0.02% | 183 |
|
|
2024
Q4 | $547K | Buy |
20,636
+30
| +0.1% | +$814 | 0.02% | 179 |
|
|
2024
Q3 | $596K | Sell |
20,606
-1,779
| -8% | -$51.9K | 0.03% | 170 |
|
|
2024
Q2 | $626K | Buy |
22,385
+2,122
| +10% | +$58.4K | 0.03% | 152 |
|
|
2024
Q1 | $562K | Sell |
20,263
-409
| -2% | -$11.3K | 0.03% | 162 |
|
|
2023
Q4 | $595K | Sell |
20,672
-4,901
| -19% | -$148K | 0.04% | 151 |
|
|
2023
Q3 | $848K | Sell |
25,573
-677
| -3% | -$23.9K | 0.06% | 136 |
|
|
2023
Q2 | $963K | Sell |
26,250
-9,213
| -26% | -$359K | 0.06% | 133 |
|
|
2023
Q1 | $1.45M | Sell |
35,463
-32,823
| -48% | -$1.42M | 0.11% | 102 |
|
|
2022
Q4 | $3.5M | Sell |
68,286
-19,669
| -22% | -$943K | 0.31% | 68 |
|
|
2022
Q3 | $3.86M | Sell |
87,955
-7,454
| -8% | -$362K | 0.36% | 57 |
|
|
2022
Q2 | $5M | Buy |
95,409
+26,472
| +38% | +$1.35M | 0.47% | 49 |
|
|
2022
Q1 | $3.58M | Buy |
68,937
+35,163
| +104% | +$1.82M | 0.29% | 58 |
|
|
2021
Q4 | $1.99M | Buy |
33,774
+33,748
| +129,800% | +$1.67M | 0.16% | 85 |
|
|
2021
Q3 | $26K | Sell |
26
-25,820
| -100% | -$1.14M | ﹤0.01% | 447 |
|
|
2021
Q2 | $1.01M | Buy |
25,846
+2,264
| +10% | +$88K | 0.1% | 102 |
|
|
2021
Q1 | $854K | Buy |
23,582
+558
| +2% | +$19.8K | 0.1% | 99 |
|
|
2020
Q4 | $847K | Sell |
23,024
-3,932
| -15% | -$144K | 0.12% | 80 |
|
|
2020
Q3 | $938K | Buy |
26,956
+5,562
| +26% | +$195K | 0.2% | 61 |
|
|
2020
Q2 | $663K | Hold |
21,394
| – | – | 0.15% | 74 |
|
|
2020
Q1 | $662K | Buy |
21,394
+88
| +0.4% | +$3K | 0.19% | 73 |
|
|
2019
Q4 | $791K | Sell |
21,306
-66
| -0.3% | -$2.35K | 0.2% | 66 |
|
|
2019
Q3 | $728K | Sell |
21,372
-165
| -0.8% | -$6K | 0.21% | 63 |
|
|
2019
Q2 | $885K | Sell |
21,537
-317
| -1% | -$12.6K | 0.26% | 60 |
|
|
2019
Q1 | $880K | Buy |
21,854
+317
| +1% | +$12.7K | 0.26% | 58 |
|
|
2018
Q4 | $891K | Sell |
21,537
-348
| -2% | -$14.4K | 0.31% | 51 |
|
|
2018
Q3 | $919K | Sell |
21,885
-401
| -2% | -$15.4K | 0.25% | 51 |
|
|
2018
Q2 | $768K | Sell |
22,286
-402
| -2% | -$13.7K | 0.23% | 54 |
|
|
2018
Q1 | $763K | Sell |
22,688
-601
| -3% | -$20.7K | 0.25% | 54 |
|
|
2017
Q4 | $800K | Sell |
23,289
-193
| -0.8% | -$6.58K | 0.28% | 57 |
|
|
2017
Q3 | $805K | Sell |
23,482
-743
| -3% | -$23.9K | 0.29% | 56 |
|
|
2017
Q2 | $767K | Sell |
24,225
-1,520
| -6% | -$47.9K | 0.29% | 63 |
|
|
2017
Q1 | $835K | Sell |
25,745
-192
| -0.7% | -$6.05K | 0.36% | 54 |
|
|
2016
Q4 | $799K | Buy |
25,937
+643
| +3% | +$19.6K | 0.42% | 50 |
|
|
2016
Q3 | $812K | Sell |
25,294
-600
| -2% | -$20.1K | 0.47% | 43 |
|
|
2016
Q2 | $865K | Sell |
25,894
-296
| -1% | -$9.45K | 0.55% | 42 |
|
|
2016
Q1 | $736K | Buy |
26,190
+8,499
| +48% | +$243K | 0.51% | 41 |
|
|
2015
Q4 | $541K | Buy |
+17,691
| New | +$557K | 0.37% | 52 |
|
Other funds holding PFE
Gerber Kawasaki Wealth & Investment Management's PFE Position: Q2 2026 in Review
Gerber Kawasaki Wealth & Investment Management reduced its Pfizer (PFE) stake by 8.7% in Q2 2026, selling an estimated $48.9K and leaving 19,574 shares worth $471K. The position accounts for 0.01% of the portfolio, ranked #239.
Gerber Kawasaki Wealth & Investment Management first reported a position in PFE in Q4 2015 and has held it in 43 quarters since. The position peaked at $5M in Q2 2022. 2,239 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Gerber Kawasaki Wealth & Investment Management held 19,574 shares of Pfizer worth $471K as of Q2 2026.
- Gerber Kawasaki Wealth & Investment Management sold 1,868 Pfizer shares in Q2 2026, an estimated $48.9K.
- Pfizer made up 0.01% of Gerber Kawasaki Wealth & Investment Management's portfolio in Q2 2026, its #239 holding.
- Gerber Kawasaki Wealth & Investment Management first reported a position in Pfizer in Q4 2015 and has held it in 43 quarters since.
- Gerber Kawasaki Wealth & Investment Management's Pfizer position peaked at $5M in Q2 2022.
- 2,239 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.